標(biāo)題: Titlebook: Ocular Pharmacology and Toxicology; Brian C. Gilger Book 2014 Springer Science+Business Media New York 2014 Drug delivery to the eye.Ocula [打印本頁] 作者: autoantibodies 時(shí)間: 2025-3-21 17:48
書目名稱Ocular Pharmacology and Toxicology影響因子(影響力)
書目名稱Ocular Pharmacology and Toxicology影響因子(影響力)學(xué)科排名
書目名稱Ocular Pharmacology and Toxicology網(wǎng)絡(luò)公開度
書目名稱Ocular Pharmacology and Toxicology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Ocular Pharmacology and Toxicology被引頻次
書目名稱Ocular Pharmacology and Toxicology被引頻次學(xué)科排名
書目名稱Ocular Pharmacology and Toxicology年度引用
書目名稱Ocular Pharmacology and Toxicology年度引用學(xué)科排名
書目名稱Ocular Pharmacology and Toxicology讀者反饋
書目名稱Ocular Pharmacology and Toxicology讀者反饋學(xué)科排名
作者: TSH582 時(shí)間: 2025-3-21 22:05
Chemistry, Manufacturing, and Control of Ophthalmic Formulations,, development of formulations matching target product profile, selection of suitable packaging, stability assessment, and critical aspects of manufacturing. Uniqueness and challenges associated with ophthalmic formulation development are also described. The chapter further outlines the regulatory requirements necessary to file IND and NDA.作者: expunge 時(shí)間: 2025-3-22 03:57
Methods in Pharmacology and Toxicologyhttp://image.papertrans.cn/o/image/700565.jpg作者: crumble 時(shí)間: 2025-3-22 07:41 作者: STEER 時(shí)間: 2025-3-22 09:24
978-1-4939-6069-9Springer Science+Business Media New York 2014作者: 繼而發(fā)生 時(shí)間: 2025-3-22 15:35
Ocular Pharmacology and Toxicology978-1-62703-745-7Series ISSN 1557-2153 Series E-ISSN 1940-6053 作者: 設(shè)想 時(shí)間: 2025-3-22 18:39
1557-2153 logies that are tested and successful.Includes study design,.Covering ocular pharmacokinetics, pharmacodynamics, and toxicology, .Ocular Pharmacology and Toxicology. provides ophthalmologists, toxicologists, and pharmacologists with both an introduction to the proper methods for ocular pharmacology 作者: 問到了燒瓶 時(shí)間: 2025-3-22 23:31
Book 2014d pharmacologists with both an introduction to the proper methods for ocular pharmacology and toxicology as well as providing practical methodologies for conducting ocular studies.?Expert authors have contributed detailed chapters on study design, analysis, and routes to regulatory approval for vari作者: 粗語 時(shí)間: 2025-3-23 03:15 作者: COWER 時(shí)間: 2025-3-23 05:40
Nanoparticles for Drug and Gene Delivery in Treating Diseases of the Eye,lity, in vitro drug release, and stability. Methods for the measurement of these parameters, which influence the performance characteristics of nanoparticles in vivo, are also discussed in this chapter.作者: CHANT 時(shí)間: 2025-3-23 12:03 作者: Abutment 時(shí)間: 2025-3-23 16:58
Brian C. Gilger this enzyme can also be reduced by removal of the N-terminal aminogroup. Substitution of D-arginine in position 8 for the naturally occurring L isomer not only inhibits metabolism by a carboxypeptidase but it also deprives the peptide of its smooth muscle stimulating property. When vasopressin is c作者: gusher 時(shí)間: 2025-3-23 22:05 作者: 令人不快 時(shí)間: 2025-3-24 00:27
ted but with little, if any, correlation to clinical disease. Both noted complexes in patients with elevated liver enzymes and inhibitors and one found inhibitor activity in the complex. The development of sensitive tests for the presence of immune complexes allowed an investigation of the patients 作者: attenuate 時(shí)間: 2025-3-24 04:03 作者: malapropism 時(shí)間: 2025-3-24 08:45
Kishore Cholkar,Aswani Dutt Vadlapudi,Hoang M. Trinh,Ashim K. Mitras they can be so made, genealogies; and will then truly give what may be called the plan of creation.” It is now possible to construct such genealogies on the basis of, for example, the similarities and differences of genomic DNA sequences in different species. But such genealogies do not reveal the作者: 音樂戲劇 時(shí)間: 2025-3-24 14:41
s they can be so made, genealogies; and will then truly give what may be called the plan of creation.” It is now possible to construct such genealogies on the basis of, for example, the similarities and differences of genomic DNA sequences in different species. But such genealogies do not reveal the作者: 原告 時(shí)間: 2025-3-24 18:52 作者: Sinus-Node 時(shí)間: 2025-3-24 20:13 作者: 引起 時(shí)間: 2025-3-25 01:29
Leandro B. C. Teixeira,James A. RenderMarco Righetti [3], we decided to work on a book in order to critically encou- rage more scientists to work and publish in this field with a high scientific standard. What we had in mind was a useful contribution to the goal to lift research on UHD and homoeo- pathy to an internationally acceptable scientific978-90-481-4359-7978-94-015-8342-8作者: 憤憤不平 時(shí)間: 2025-3-25 05:24 作者: corporate 時(shí)間: 2025-3-25 08:52
Malay Ghosh,Imran AhmedWhether as a primary source or as inspirational reading, we feel this book has a place in every library. The material comes from an international meeting held i978-90-481-4090-9978-94-015-8054-0Series ISSN 0068-0346 Series E-ISSN 2214-7942 作者: LEERY 時(shí)間: 2025-3-25 13:43
David A. WilkieWhether as a primary source or as inspirational reading, we feel this book has a place in every library. The material comes from an international meeting held i978-90-481-4090-9978-94-015-8054-0Series ISSN 0068-0346 Series E-ISSN 2214-7942 作者: 繼承人 時(shí)間: 2025-3-25 16:18
1557-2153 mine pharmacokinetics and ocular toxicity from the systemic, topical, periocular, or intraocular administration of drugs or compounds, from the use of ocular medical devices and from ocular surgical procedures..978-1-4939-6069-9978-1-62703-745-7Series ISSN 1557-2153 Series E-ISSN 1940-6053 作者: bonnet 時(shí)間: 2025-3-25 22:18
Compositions, Formulation, Pharmacology, Pharmacokinetics, and Toxicity of Topical, Periocular, and back of the eye diseases. Though intravitreal route appears to be promising to attain high drug concentrations in back of the eye tissues, however, this route is often limited by postdosing adverse effects such as retinal detachment and endophthalmitis. Periocular injections are associated with fai作者: certitude 時(shí)間: 2025-3-26 00:12
Challenges in Ocular Pharmacokinetics, Pharmacodynamics, and Toxicology,作者: MUTED 時(shí)間: 2025-3-26 05:33
Selection of Appropriate Animal Models in Ocular Research: Ocular Anatomy and Physiology of Common 作者: cushion 時(shí)間: 2025-3-26 10:44 作者: HARD 時(shí)間: 2025-3-26 16:13
Sustained-Release Ocular Drug Delivery Systems: Bench to Bedside Development,作者: OASIS 時(shí)間: 2025-3-26 20:30
The Ophthalmic Examination as It Pertains to General Ocular Toxicology: Basic and Advanced Techniqu作者: In-Situ 時(shí)間: 2025-3-26 22:37
Study Design and Methodologies for Evaluation of Anti-glaucoma Drugs,作者: Offset 時(shí)間: 2025-3-27 04:36
Study Design and Methodologies for Study of Ocular Medical Devices,作者: SEEK 時(shí)間: 2025-3-27 08:41 作者: EXALT 時(shí)間: 2025-3-27 12:14
Book 2014asis of training in the proper design and conduct of essential studies to accurately determine pharmacokinetics and ocular toxicity from the systemic, topical, periocular, or intraocular administration of drugs or compounds, from the use of ocular medical devices and from ocular surgical procedures..作者: painkillers 時(shí)間: 2025-3-27 13:36
Glasgow. The purpose of the meeting was to highlight the growing areas of haemophilia care and research as they serve as a model for the study of other disorders. In particular a major section of these proceedings is devoted to the investigation of liver disease in haemophili- an area which offers 作者: febrile 時(shí)間: 2025-3-27 20:51
Brian C. Gilgeronditions. Factor VIII levels can be increased pharmacologically by stimulation of beta.-receptors. and by vasopressin and some of its synthetic analogues. Infusion of vasopressin intravenously, however, is also accompanied by contraction of smooth muscle in blood vessel walls, gastrointestinal trac作者: GROVE 時(shí)間: 2025-3-27 22:33 作者: 礦石 時(shí)間: 2025-3-28 04:38
or bleeding episodes and availability of lyophilized clotting factor. However, 10–15% of patients with severe deficiencies of Factor VIII and IX continue to have progressive joint disease despite adequate treatment for bleeding episodes. We have confirmed this observation of Levine. in an adult popu作者: 車床 時(shí)間: 2025-3-28 07:52 作者: 易于出錯(cuò) 時(shí)間: 2025-3-28 12:43
Cornelis J. Van der Schyf,Samuel D. Crish,Christine Crish,Denise Inman,Werner J. Geldenhuyshe metallist tradition long dominated economics, modern thinkers no longer hold that the acceptance of money as a medium of exchange should be understood as resting on a belief in the intrinsic value possessed by money itself. When Frank Hahn sought to lay the groundwork for an adequate theory of mo作者: Flinch 時(shí)間: 2025-3-28 16:32 作者: 閑逛 時(shí)間: 2025-3-28 19:00
ned so that certain forms are possible and other are not. A possible consequence of this is that the hierarchical taxonomies of organisms arise not from dichotomous branching due to the historical winnowing process of natural selection, producing a discrete spectrum from an initial continuum, but fr作者: 災(zāi)難 時(shí)間: 2025-3-29 01:41 作者: 漫不經(jīng)心 時(shí)間: 2025-3-29 03:19
Paul E. Miller in the metamorphosis of these animals..The highly diluted thyroxine (10., 1.125 × 10.M, “D30”) to a small but statistically significant extent slows down the climbing activity of juvenile frogs, when once added dropwise to the aquaria water at the juvenile stage. It is also demonstrated that this d作者: Predigest 時(shí)間: 2025-3-29 10:22
Joseph W. Carraway,Elaine M. Daniel in the metamorphosis of these animals..The highly diluted thyroxine (10., 1.125 × 10.M, “D30”) to a small but statistically significant extent slows down the climbing activity of juvenile frogs, when once added dropwise to the aquaria water at the juvenile stage. It is also demonstrated that this d作者: 姑姑在炫耀 時(shí)間: 2025-3-29 12:46 作者: Gustatory 時(shí)間: 2025-3-29 17:41 作者: 哭得清醒了 時(shí)間: 2025-3-29 21:43
Chemistry, Manufacturing, and Control of Ophthalmic Formulations,, development of formulations matching target product profile, selection of suitable packaging, stability assessment, and critical aspects of manufacturing. Uniqueness and challenges associated with ophthalmic formulation development are also described. The chapter further outlines the regulatory re作者: 多嘴 時(shí)間: 2025-3-30 03:13
ADME and Ocular Therapeutics: Retina,he development of orally available drugs that can reach the posterior segment of the eye is hampered by the anatomy of the eye. In this chapter, we describe methods for obtaining and analyzing retina and associated optic tract structures for drug levels. These techniques can be used in drug developm作者: 積習(xí)難改 時(shí)間: 2025-3-30 05:12
Compositions, Formulation, Pharmacology, Pharmacokinetics, and Toxicity of Topical, Periocular, andologists and drug delivery scientists. Designing an effective therapy for ophthalmic disorders, especially for the chronic posterior segment diseases, has been considered a formidable task. Ocular static, dynamic, and precorneal barriers prevent administered drug from reaching the target site at the
